{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:24:29Z","timestamp":1787833469240,"version":"build-2784847793"},"reference-count":0,"publisher":"Hacettepe University Institute of Child Health","issue":"4","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Pediatr"],"abstract":"<jats:p>Background and Objectives. Quantification of serum Epstein-Barr virus (EBV) DNA and\/or cell-free total DNA (cf-DNA) may become valuable sources for prognosis evaluation and monitoring treatment response in lymphomas. We aimed to investigate their roles as potential markers in pediatric Hodgkin (HL) and non- Hodgkin lymphomas (NHL).\n\t\t\t\t\tMethod. Between the years 2005-2008, 34 patients with HL and 45 with NHL were prospectively included. Serum samples were collected upon diagnosis, after 1-3 and 4-6 months and at the end of treatment, or at disease recurrence. RT-PCR determination of cf-DNA and EBV DNA were performed using amplification of BAMH1W region of EBV genome and of human \u03b2-globin gene. Results were analyzed for correlation with clinical and pathological characteristics.\n\t\t\t\t\tResults. Median ages were 8.9 years for HL and 8.8 years for NHL cases. Twenty-three healthy children cured from various childhood cancers served as the control group. In the controls, median serum EBV DNA copy number was `0` and median serum cf-DNA level was 50 ng\/ml. At initial diagnosis, serum EBV DNA copy numbers were elevated in 20\/34 HL and 8\/45 NHL cases (p &lt; 0.001). Median serum EBV DNA copy numbers were 15987\/mL (125-6032075) and 25162 (1475-1214550) for HL and NHL cases, respectively (p= 0.9). Median serum cf-DNA levels were 435 ng\/ml (2.3-17306) in HL and 700 ng\/ml (4.9-14009) in NHLs (p= 0.12). Serum EBV DNA copy numbers and cf-DNA levels decreased significantly after induction treatment and in the follow-up. In 10\/13 NHL cases with a relapse, marked elevations were detected in serum cf-DNA levels at recurrences. No significant differences were detected between median cf-DNA levels according to disease stages, response status to treatment or presence of recurrent disease.\n\t\t\t\t\tConclusion. Serum EBV DNA copy numbers and cf-DNA levels were elevated at initial diagnosis in both HLs and NHLs and decreased parallel to treatment response. In NHL cases, remarkable elevation of cf-DNA levels at recurrences indicated that cf-DNA levels might be useful in the follow-up of pediatric NHLs.<\/jats:p>","DOI":"10.24953\/turkjped.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T12:06:42Z","timestamp":1597061202000},"page":"541-550","source":"Crossref","is-referenced-by-count":6,"title":["Circulating Epstein-Barr virus DNA and cell-free DNA in pediatric lymphomas"],"prefix":"10.24953","volume":"62","author":[{"given":"Bilgehan","family":"Yal\u00e7\u0131n","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, Hacettepe University Cancer Institute and Faculty of Medicine, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tezer","family":"Kutluk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hacettepe University Cancer Institute and Faculty of Medicine; Drug Resistance Laboratory, Hacettepe University Oncology Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil Kahraman","family":"A\u011fbaba","sequence":"additional","affiliation":[{"name":"Drug Resistance Laboratory, Hacettepe University Oncology Hospital, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Demir","sequence":"additional","affiliation":[{"name":"Drug Resistance Laboratory, Hacettepe University Oncology Hospital, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beril","family":"Talim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10580","published-online":{"date-parts":[[2020,8,28]]},"container-title":["The Turkish Journal of Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/turkjpediatr.org\/article\/download\/482\/481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/turkjpediatr.org\/article\/download\/482\/481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:06:55Z","timestamp":1787832415000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjpediatr.org\/article\/view\/482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,8,28]]}},"URL":"https:\/\/doi.org\/10.24953\/turkjped.2020.04.003","relation":{},"ISSN":["2791-6421","0041-4301"],"issn-type":[{"value":"2791-6421","type":"electronic"},{"value":"0041-4301","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}